Your Article Summary
See Latest ArticlesExpression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients
Gynecologic Oncology, 07/01/09
Wang L et al. - The expression of uPA/uPAR was associated with EOC progression. uPA/uPAR are useful markers for EOC prognosis and could be promising therapeutic targets for treating incurable, recurrent EOC.
Related Articles
Preventing future cancers by testing women with ovarian cancer for brca mutations
Journal of Clinical Oncology, 10/22/09
Relevance Score: 72%
Activity of the multikinase inhibitor dasatinib against ovarian cancer cells
British Journal of Cancer, 11/02/09
Relevance Score: 70%
Unusual Metals Could Forge New Cancer Drug
ScienceDaily, 10/20/09
Relevance Score: 70%
New Drug Aims To Seek And Destroy Many Types Of Cancer
ScienceDaily, 10/07/09
Relevance Score: 70%
New drug aims to seek and destroy many types of cancer
EurekAlert, 10/06/09
Relevance Score: 70%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Polycomb group protein Bmi1 expression in colon cancers predicts the survival
Medical Oncology, 12/15/09
Decreased expression of KLF6 and its significance in gastric carcinoma
Medical Oncology, 12/15/09
Gene-expression-based analysis of local and metastatic neuroblastoma variants reveals a set of genes associated with tumor progression in neuroblastoma patients
International Journal of Cancer, 12/15/09
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk
Carcinogenesis, 12/15/09
The process of deciding about prophylactic surgery for breast and ovarian cancer: Patient questions, uncertainties, and communication
American Journal of Medical Genetics, 12/15/09
Coexistent atypical polypoid adenomyoma and complex atypical endometrial hyperplasia in the uterus
Diagnostic Cytopathology, 12/15/09